Quellen "Aktuelle Aspekte zur Epidemiologie und Klinik von COVID-19 und Typ-2-Diabetes"

DDG Geschäftsbericht 2021

Literatur

1. Müller JA, et al. Nat Metab. 2021; 3:149-165. 

2. Sathish T, et al. Diabetes Metab 2021; 47:101204.   

3. Hartmann-Boyce J, et al. Diabetes Care. 2021; 44:2790-2811. 

4. Stefan N, et al. Nat Rev Endocrinol. 2021; 17:135-149.  

5. Rathmann W, et al. Diabetologia 2022 [im Druck]  

6. Stefan N. Nat Rev Endocrinol. 2022; 18:75-76 

7. Khunti K, et al. Diabetes Care. 2021; 44:2645-2655. 

8. Kowall B, et al. Diabetes Res Clin Pract. 2021; 179:109002. 

9. Kowall B, et al. [im Reviewverfahren] 

Weitere Quellen:

Bernd Kowall, Karel Kostev, Rüdiger Landgraf, Hans Hauner, Ralf Bierwirth, Wolfgang Rathmann: Effects of the COVID-19 pandemic on clinically diagnosed psychiatric disorders in persons with type 2 diabetes

Wolfgang Rathmann, Oliver Kuss, Karel Kostev: Incidence of newly diagnosed diabetes after Covid-19

Bernd Kowall, Karel Kostev, Ru¨ diger Landgraf, Hans Haunerd, Ralf Bierwirth, Wolfgang Rathmann: Effects of the COVID-19 lockdown on primary
health care for persons with type 2 diabetes – Results from the German Disease Analyzer database